Clinical Trial Update: A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting [Phase 4]

View source ↗

Summary

A single-center randomized Phase 4 study compares ticagrelor with clopidogrel for antiplatelet effects in patients on dual antiplatelet therapy after coronary a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Antiplatelet Therapy of Coronary Artery Bypass | Phase 4 | Status: COMPLETED